BeyondSpring is trading at $0.66, up 8.93%, with no clear catalyst identified for the October 12 move.
- The latest company announcement located was September 29, about FDA Fast Track designation and a strategic transaction; no new announcement today was identified.
- Broad-market conditions were mixed, with index moves below 0.5% in either direction, so they do not clearly explain the gain.
- Available coverage does not establish a specific trading-volume explanation.